Literature DB >> 24275104

Impact of clinical inertia on cardiovascular risk factors in patients with diabetes.

David L Whitford1, Hussam A Al-Anjawi2, Marwa M Al-Baharna2.   

Abstract

AIMS: To determine whether clinical inertia is associated with simpler interventions occurring more often than complex changes and the association between clinical inertia and outcomes.
METHODS: Prevalence of clinical inertia over a 30 month period for hyperglycaemia, hypertension and dyslipidaemia was calculated in a random sample (n=334) of patients attending a diabetes clinic. Comparisons between prevalence of clinical inertia and outcomes for each condition were examined using parametric tests of association.
RESULTS: There was less clinical inertia in hyperglycaemia (29% of consultations) compared with LDL (80% of consultations) and systolic BP (68% of consultations). Consultations where therapy was intensified had a greater reduction in risk factor levels than when no change was made. No association was found between treatment intensity scores and changes in HbA1c, LDL or blood pressure over 30 months.
CONCLUSIONS: Physicians are no more likely to intervene in conditions where simple therapeutic changes are necessary as opposed to complex changes. Greater clinical inertia leads to poorer outcomes. There continues to be substantial clinical inertia in routine clinical practice. Physicians should adopt a holistic approach to cardiovascular risk reduction in patients with diabetes, adhere more closely to established management guidelines and emphasize personal individualized target setting.
Copyright © 2013 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Clinical inertia; Diabetes mellitus; Hyperlipidaemia; Hypertension

Mesh:

Substances:

Year:  2013        PMID: 24275104     DOI: 10.1016/j.pcd.2013.10.007

Source DB:  PubMed          Journal:  Prim Care Diabetes        ISSN: 1878-0210            Impact factor:   2.459


  9 in total

1.  "Teeth are always in style": but increasingly, not for all.

Authors:  Athanasios I Zavras
Journal:  Health Serv Res       Date:  2014-04       Impact factor: 3.402

2.  Therapeutic Inertia: Still a Long Way to Go That Cannot Be Postponed.

Authors:  Manel Mata-Cases; Josep Franch-Nadal; Mònica Gratacòs; Dídac Mauricio
Journal:  Diabetes Spectr       Date:  2020-02

3.  Clinical Characteristics and Unmet Need Among Patients with Atherosclerotic Cardiovascular Disease Stratified by Statin Use.

Authors:  Qing Huang; Michael Grabner; Robert J Sanchez; Vincent J Willey; Mark J Cziraky; Swetha R Palli; Thomas P Power
Journal:  Am Health Drug Benefits       Date:  2016-11

4.  Overview of Therapeutic Inertia in Diabetes: Prevalence, Causes, and Consequences.

Authors:  Susan L Karam; Jared Dendy; Shruti Polu; Lawrence Blonde
Journal:  Diabetes Spectr       Date:  2020-02

Review 5.  Gaps and barriers in the control of blood glucose in people with type 2 diabetes.

Authors:  Lawrence Blonde; Pablo Aschner; Clifford Bailey; Linong Ji; Lawrence A Leiter; Stephan Matthaei
Journal:  Diab Vasc Dis Res       Date:  2017-02-01       Impact factor: 3.291

6.  Prevalence and Control of Dyslipidemia in Patients Referred for High Blood Pressure: The Disregarded "Double-Trouble" Lipid Profile in Overweight/Obese.

Authors:  Francesco Spannella; Federico Giulietti; Chiara Di Pentima; Riccardo Sarzani
Journal:  Adv Ther       Date:  2019-04-05       Impact factor: 3.845

7.  Type 2 diabetes and healthcare resource utilisation in the Kingdom of Bahrain.

Authors:  Rabha AbdulAziz Salman; Adel Salman AlSayyad; Craig Ludwig
Journal:  BMC Health Serv Res       Date:  2019-12-05       Impact factor: 2.655

8.  Barriers and Facilitators to the Initiation of Injectable Therapies for Type 2 Diabetes Mellitus: A Mixed Methods Study.

Authors:  Simon de Lusignan; Andrew McGovern; William Hinton; Martin Whyte; Neil Munro; Emily D Williams; Afrodita Marcu; John Williams; Filipa Ferreira; Julie Mount; Manasa Tripathy; Emmanouela Konstantara; Benjamin C T Field; Michael Feher
Journal:  Diabetes Ther       Date:  2022-09-02       Impact factor: 3.595

9.  Hypertension guidances published in 2013: a busy year with more to follow.

Authors:  J Rick Turner; Snehal Kothari
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-03-19       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.